Cover Image
市場調查報告書

生物醫藥品市場:全球市場方案,市場規模,預測,趨勢,及預測

Biopharmaceuticals Market (By TypeMonoclonal Antibodies, Recombinant Proteins, Granulocyte Colony-Stimulating Factor, Interferon, & Others; By Therapeutic Application; By Geography) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

出版商 Variant Market Research LLP 商品編碼 550293
出版日期 內容資訊 英文 115 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物醫藥品市場:全球市場方案,市場規模,預測,趨勢,及預測 Biopharmaceuticals Market (By TypeMonoclonal Antibodies, Recombinant Proteins, Granulocyte Colony-Stimulating Factor, Interferon, & Others; By Therapeutic Application; By Geography) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
出版日期: 2017年08月28日 內容資訊: 英文 115 Pages
簡介

本報告提供全球生物醫藥品市場相關調查,彙整市場概要和各類型,各治療用途,地區別趨勢,及打入市場的主要企業簡介等資料。

第1章 序論

第2章 摘要整理

第3章 市場概要

  • 市場概要,趨勢,預測,觀點
  • 市場佔有率分析:企業競爭模式
  • 價值鏈分析
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 波特五力分析

第4章 各類型市場:市場規模與預測

  • 概要
  • 單株抗體
  • 重組蛋白
  • 顆粒細胞增生因子
  • 干擾素
  • 重組胰島素注射液
  • 促血紅細胞生長素
  • 疫苗
  • 生長激素
  • 純化蛋白
  • 其他類型

第5章 各治療用途市場:市場規模與預測

  • 概要
  • 腫瘤
  • 發炎性感染疾病
  • 代謝性疾病
  • 心血管疾病
  • 其他

第6章 各地區市場:市場規模與預測

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第7章 企業簡介

目錄

Title:
Biopharmaceuticals Market
(Monoclonal Antibodies, Recombinant Proteins, Granulocyte Colony-Stimulating Factor, Interferon, Recombinant Human Insulin, Erythropoietin, Vaccines, Growth Hormones, Purified Proteins; Oncology, Inflammatory Infectious Diseases, Metabolic Disorders, Cardiovascular Diseases; North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024.

Global Biopharmaceuticals Market is estimated to reach $405 billion by 2024; growing at a CAGR of 9.3% from 2016 to 2024. Biopharmaceuticals are proteins and nucleic acids that are produced by means of recombinant DNA techniques, purification processes, and hybridoma techniques. The production of these medical drugs mainly involves transgenic organisms, largely plants, and animals that have been genetically modified to produce drugs. Biopharmaceuticals are basically proteins in nature comprising of antibodies and nucleic acids and are used for vivo diagnostic purpose and therapeutic. They aid in the treatment of several chronic diseases including metabolic, cardiovascular, neurological, cancer and other intermittent diseases for which no other treatments are available at present.

Advanced technologies, improved efficiency as compared to conventional drugs, and increasing prevalence of autoimmune diseases and cancer are the major factors driving the growth of the global biopharmaceuticals market. Additionally, increasing government investments for the development of advanced products, and growing preference of herbal medicines could offer future scope in the coming years. Though, possibility of adverse effects and presence of low priced biosimilars could limit the adoption among end users.

The global biopharmaceuticals market has been categorized into type, therapeutic application, and geography. Type segment is bifurcated into purified proteins, interferon, monoclonal antibodies, granulocyte colony-stimulating factor (G-CSF), recombinant proteins, recombinant human insulin, erythropoietin, vaccines, growth hormones, and others. Therapeutic application is further segmented into oncology, metabolic disorders, inflammatory infectious diseases, cardiovascular diseases, and others.

By geography, the biopharmaceuticals market has been categorized into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers Germany, UK, France, Italy, and others. Asia-Pacific covers India, Japan, China, and others. Rest of the World (RoW) covers South America, Middle East, and Africa.

The key players in the global biopharmaceuticals market include Eli Lilly and Company, Biocon Ltd, Roche Holding AG, Bayer AG, Johnson & Johnson, Inc, Genentech, Inc., Abbott Laboratories, Ranbaxy Laboratories Ltd., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, and Biogen, Inc, among others.

The key takeaways from the report:

  • The report will provide detailed analysis of Biopharmaceuticals Market with respect to major segments such as type, and therapeutic application
  • The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024
  • Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
  • An exhaustive regional analysis of Biopharmaceuticals Market has been included in the report
  • Profile of the key players of the Biopharmaceuticals Market will be provided, which include key financials, product & services, new developments and business strategies

Scope of Biopharmaceuticals Market:

Type Segments

  • Purified Proteins
  • Interferon
  • Monoclonal Antibodies
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Recombinant Proteins
  • Recombinant Human Insulin
  • Erythropoietin
  • Vaccines
  • Growth Hormones
  • Other Types

Therapeutic Application segments

  • Oncology
  • Metabolic Disorders
  • Inflammatory Infectious Diseases
  • Cardiovascular Diseases
  • Other Therapeutic Applications

Geography Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Others
  • Asia-Pacific
    • India
    • Japan
    • China
    • Others
  • RoW
    • South America
    • Middle East
    • Africa

Table of Contents

Chapter 1: Prefix

  • 1.1. Market Scope
  • 1.2. Report Description
  • 1.3. Research Methodology
    • 1.3.1. Primary Research
    • 1.3.2. Secondary Research
    • 1.3.3. In-house Data Modeling

Chapter 2: Executive Summary

Chapter 3: Market Outline

  • 3.1. Market Inclination, Trend, Outlook and Viewpoint
  • 3.2. Market Share Analysis: Company's Competitive Scenario
  • 3.3. Value Chain Analysis
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Impact Analysis
    • 3.4.2. Restraints
      • 3.4.2.1. Impact Analysis
    • 3.4.3. Opportunities
  • 3.5. Porter's five forces analysis
    • 3.5.1. Factors Impact Analysis

Chapter 4: Biopharmaceuticals Market by Type: Market Size and Forecast, 2015-2024

  • 4.1. Overview
  • 4.2. Monoclonal Antibodies
    • 4.2.1. Current Trend and Analysis
    • 4.2.2. Market Size and Forecast
  • 4.3. Recombinant Proteins
    • 4.3.1. Current Trend and Analysis
    • 4.3.2. Market Size and Forecast
  • 4.4. Granulocyte Colony-Stimulating Factor (G-CSF)
    • 4.4.1. Current Trend and Analysis
    • 4.4.2. Market Size and Forecast
  • 4.5. Interferon
    • 4.5.1. Current Trend and Analysis
    • 4.5.2. Market Size and Forecast
  • 4.6. Recombinant Human Insulin
    • 4.6.1. Current Trend and Analysis
    • 4.6.2. Market Size and Forecast
  • 4.7. Erythropoietin
    • 4.7.1. Current Trend and Analysis
    • 4.7.2. Market Size and Forecast
  • 4.8. Vaccines
    • 4.8.1. Current Trend and Analysis
    • 4.8.2. Market Size and Forecast
  • 4.9. Growth Hormones
    • 4.9.1. Current Trend and Analysis
    • 4.9.2. Market Size and Forecast
  • 4.10. Purified Proteins
    • 4.10.1. Current Trend and Analysis
    • 4.10.2. Market Size and Forecast
  • 4.11. Other Types
    • 4.11.1. Current Trend and Analysis
    • 4.11.2. Market Size and Forecast

Chapter 5: Biopharmaceuticals Market by Therapeutic Application: Market Size and Forecast, 2015-2024

  • 5.1. Overview
  • 5.2. Oncology
    • 5.2.1. Current Trend and Analysis
    • 5.2.2. Market Size and Forecast
  • 5.3. Inflammatory Infectious Diseases
    • 5.3.1. Current Trend and Analysis
    • 5.3.2. Market Size and Forecast
  • 5.4. Metabolic Disorders
    • 5.4.1. Current Trend and Analysis
    • 5.4.2. Market Size and Forecast
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Current Trend and Analysis
    • 5.5.2. Market Size and Forecast
  • 5.6. Other Therapeutic Applications
    • 5.6.1. Current Trend and Analysis
    • 5.6.2. Market Size and Forecast

Chapter 6: E-Clinical Solution Software Market by Geography: Market Size and Forecast, 2015-2024

  • 6.1. Overview
  • 6.2. North America
    • 6.2.1. Current Trend and Analysis
    • 6.2.2. Market Size and Forecast
    • 6.2.3. US
      • 6.2.3.1. Market Size and Forecast
    • 6.2.4. Canada
      • 6.2.4.1. Market Size and Forecast
    • 6.2.5. Mexico
      • 6.2.5.1. Market Size and Forecast
  • 6.3. Europe
    • 6.3.1. Current Trend and Analysis
    • 6.3.2. Market Size and Forecast
    • 6.3.3. UK
      • 6.3.3.1. Market Size and Forecast
    • 6.3.4. Germany
      • 6.3.4.1. Market Size and Forecast
    • 6.3.5. France
      • 6.3.5.1. Market Size and Forecast
    • 6.3.6. Italy
      • 6.3.6.1. Market Size and Forecast
    • 6.3.6. Others
      • 6.3.6.1. Market Size and Forecast
  • 6.4. Asia-Pacific
    • 6.4.1. Current Trend and Analysis
    • 6.4.2. Market Size and Forecast
    • 6.4.3. Japan
      • 6.4.3.1. Market Size and Forecast
    • 6.4.4. China
      • 6.4.4.1. Market Size and Forecast
    • 6.4.5. India
      • 6.4.5.1. Market Size and Forecast
    • 6.4.6. Others
      • 6.4.6.1. Market Size and Forecast
  • 6.5. RoW
    • 6.5.1. Current Trend and Analysis
    • 6.5.2. Market Size and Forecast
    • 6.5.3. Middle East
      • 6.5.3.1. Market Size and Forecast
    • 6.5.4. South America
      • 6.5.4.1. Market Size and Forecast
    • 6.5.5. Africa
      • 6.5.5.1. Market Size and Forecast

Chapter 7: Company Profiles

  • 7.1. Roche Holding AG
  • 7.2. Bayer AG
  • 7.3. Abbott Laboratories
  • 7.4. Biocon Ltd
  • 7.5. Eli Lilly and Company
  • 7.6. Ranbaxy Laboratories Ltd.
  • 7.7. Pfizer Inc.
  • 7.8. Novartis AG
  • 7.9. Genentech, Inc.
  • 7.10. Johnson & Johnson, Inc
Back to Top